MANILA, Philippines — The Department of Health (DOH) and the Department of Trade and Industry (DTI) should regulate prices of medicines doctors are using to treat patients afflicted with the coronavirus disease (COVID-19) in the absence of a vaccine, a lawmaker said Friday.
Quezon City Rep. Precious Hipolito Castro said these medications, which include remdesivir, hydroxychloroquine, dexamethasone, and ivermectin, could prevent the deterioration of COVID-19 and hasten the recovery of patients as per testimonies made by doctors.
“Their prices have shot up by as much as 12 times. One of these drugs now costs about P60,000, if you can find it in the market,” Castelo said.
Keep on reading: DOH, DTI urged to regulate prices of COVID-19 therapeutic drugs